Skip to main content
ARIX BIOSCIENCE PLC logo

ARIX BIOSCIENCE PLC - Investor Relations & Filings

Delisted Feb 2024 · Acquired / Merged Acquired / Merged The company was acquired by or merged into another entity, so its shares stopped trading independently.
Ticker · ARIX ISIN · GB00BD045071 LEI · 213800OVT3AHQCXNIX43 IL Financial and insurance activities
Open in API
Filings indexed 556 across all filing types
Latest filing 2021-10-06 Transaction in Own Shar…
Country GB United Kingdom
Listing IL ARIX

About ARIX BIOSCIENCE PLC

https://www.arixbioscience.com/

Arix Bioscience plc is a global venture capital company that specializes in the biotechnology and life sciences sectors. The firm's primary activity involves investing in and building innovative biotech companies, providing capital and strategic support from early stages, including seed, preclinical, and clinical development. Arix focuses on identifying and nurturing breakthrough advances in life sciences to accelerate the development of new medical technologies and therapies. According to public information, the company has entered into a process of liquidation.

Recent filings

Filing Released Lang Actions
Transaction in own shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states 'Transaction in own shares' in the title and body. It details the purchase of 39,000 ordinary shares as part of a buyback programme. Furthermore, the metadata section includes 'Category Code: POS' and 'OAM Categories: 2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (POS).
2021-10-06 English
Board Changes
Board/Management Information Classification · 100% confidence The document explicitly announces 'Board Changes' within Arix Bioscience plc, detailing the appointment of a permanent CEO, the addition of a Senior Independent Director, and the stepping down of a Non-Executive Director. This content directly aligns with the definition of 'Board/Management Information'. The document is a regulatory announcement disseminated via EQS Group, but its core subject matter is management changes, making 'MANG' the most specific classification over a general 'RNS'. The document length (4467 chars) is substantial enough to be the primary announcement, not just a placeholder for a report.
2021-10-06 English
Transaction in own shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states 'Transaction in own shares' in the title and body. It details the purchase of 36,000 ordinary shares as part of a buyback programme. Furthermore, the metadata section includes 'Category Code: POS' and 'OAM Categories: 2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (POS).
2021-10-05 English
Transaction in own shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states 'Transaction in own shares' in the title and body. It details the purchase of 36,000 ordinary shares as part of a buyback programme. Furthermore, the metadata section includes 'Category Code: POS' and 'OAM Categories: 2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (POS).
2021-10-04 English
Transaction in own shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states the subject matter in the title and body: "Transaction in own shares". It details the purchase of ordinary shares as part of a buyback programme, including the date, volume, and price. Furthermore, the metadata section explicitly lists the 'Category Code' as 'POS' and the 'OAM Categories' as '2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (POS).
2021-10-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly announces the 'Total Voting Rights' as of a specific date (30 September 2021) and references compliance with '5.6.1R of the Disclosure Guidance and Transparency Rules'. It details the total issued share capital, shares held in Treasury, and the resulting number of shares with voting rights (129,692,800). This type of announcement, which relates to the total number of shares and voting power, is a specific regulatory disclosure. Reviewing the definitions, this content most closely aligns with the information covered under 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it directly relates to the mechanics of voting rights, although it is a static count rather than the result of a vote. However, the OAM Category listed is '2.5. Total number of voting rights and capital', which is a standard regulatory disclosure. Since DVA specifically mentions 'Voting Results', and this is a 'Total Voting Rights' announcement, it is a close fit. If a more specific code existed for 'Total Voting Rights', it would be preferred. Given the options, DVA is the closest fit related to voting mechanics. Alternatively, since it is a regulatory announcement about capital structure components, it could potentially fall under CAP (Capital/Financing Update) or RNS (Regulatory Filings). Given the explicit mention of 'voting rights' and the context of shareholder determination, DVA is the most precise fit among the provided options for a disclosure concerning the denominator used for shareholder influence calculations.
2021-10-01 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.